Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies

Author:

Martin Antony P.,Downing Jennifer,Cochrane Madeleine,Collins Brendan,Francis Ben,Haycox Alan,Alfirevic Ana,Pirmohamed Munir

Funder

National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC)

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference98 articles.

1. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts;Abboud;Blood,2013

2. Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA;Ades;PLoS Med.,2017

3. Treatment challenges and survival analysis of human epidermal growth factor receptor 2 ‑ positive breast Cancer in real world;Adusumilli;Indian J. Med. Paediatr. Oncol.,2017

4. Taking up Africa’s cancer challenge. Botswana, Kenya and Rwanda have started to provide cancer care in their national efforts to achieve universal coverage of health services;Anderson;Bull. World Health Organ.,2018

5. Which is more important for doctors in a middle-income country, a national guideline or the medical literature? An adherence survey of trastuzumab use for breast cancer in Iran;Ansaripour;J. Cancer Policy,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3